| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5699770 | Clinical Oncology | 2008 | 6 Pages |
Abstract
We have shown that pre-treatment raised serum urea is a significant predictor of early death. This readily available information will be useful for assessing SCLC patients at the bedside and discussing the risks of chemotherapy with them.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
M.C. Winter, V.A. Potter, P.J. Woll,